TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33258049

Group type: EXPERIMENTAL
Intervention: Interpersonal and traditional mass media sources
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Health-related media such as pharmacy magazines
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Health professionals
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Internet
Number of subjects: 1001
Study: 32712155

Group type: EXPERIMENTAL
Intervention: Carboplatin‐paclitaxel + nintedanib
Number of subjects: 119

Group type: COMPARATOR
Intervention: Carboplatin‐paclitaxel
Number of subjects: 119
Study: 35435875

Group type: EXPERIMENTAL
Intervention: Benson relaxation technique combined with music therapy
Number of subjects: 61
Study: 32630191

Group type: EXPERIMENTAL
Intervention: Lixisenatide (10 mcg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35263280

Group type: EXPERIMENTAL
Intervention: Intratracheal oxygen administration
Number of subjects: 6

Group type: COMPARATOR
Intervention: Intranasal oxygen administration
Number of subjects: 6
Study: 34536433

Group type: EXPERIMENTAL
Intervention: Endurance ergometer cycling (EC)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Muscle strengthening whole body vibration (WBV)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 64
Study: 34119270

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 1102

Group type: EXPERIMENTAL
Intervention: Combined cilostazol and aspirin therapy
Number of subjects: 1102
Study: 32179965

Group type: EXPERIMENTAL
Intervention: 5-hour basic training program for RA patients
Number of subjects: 249

Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 249
Study: 35752566

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 104

Group type: COMPARATOR
Intervention: iGlar + gliclazide
Number of subjects: 104
Study: 33452064

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia for HIE
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Early model variables (HIE severity, epinephrine administration, respiratory support, fraction of inspired oxygen of 0.21 at admission)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Cumulative model variables (Severity of EEG findings, HIE severity, use of steroids for blood pressure management, significant brain injury on MRI)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Early model
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Cumulative model
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Validation cohort
Number of subjects: 486
Study: 34215800

Group type: EXPERIMENTAL
Intervention: Topical capsaicin applied to the left upper back
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo topical cream applied to the left upper back
Number of subjects: 20
Study: 32122449

Group type: EXPERIMENTAL
Intervention: Vitamin D₃ deficiency group (serum 25-OH vitamin D₃ levels low)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vitamin D₃ deficiency group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 100
Study: 36303113

Group type: EXPERIMENTAL
Intervention: Non-linear periodized aerobic exercise (NLPE) for 8 weeks (n = 28)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Standard exercise recommendations (n = 15)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Non-linear periodized aerobic exercise (NLPE)
Number of subjects: 43
Study: 33168545

Group type: EXPERIMENTAL
Intervention: Abatacept 125 mg weekly subcutaneous for 169 days
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 32014238

Group type: EXPERIMENTAL
Intervention: Participant-controlled intravenous rehydration with 4% dextrose in 0.18% sodium chloride, bolus volumes of 50 ml (low volume) or 200 ml (high volume), triggered by thirst.
Number of subjects: 10
Study: 35575148

Group type: EXPERIMENTAL
Intervention: Conventional exercise training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-load inspiratory muscle training (IMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-load inspiratory muscle training (IMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No inspiratory muscle training (IMT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gluteal muscle size
Number of subjects: 0
Study: 33532898

Group type: EXPERIMENTAL
Intervention: Double Reverse Traction Repositor (DRTR)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Manual Traction (MT)
Number of subjects: 77
Study: 33287395

Group type: EXPERIMENTAL
Intervention: Price promotions on unhealthy foods at end of aisles
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Price promotions on unhealthy foods at island bins
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Price promotions on unhealthy foods at checkouts
Number of subjects: 104

Group type: COMPARATOR
Intervention: Price promotions on healthy foods
Number of subjects: 104
Study: 35872962

Group type: EXPERIMENTAL
Intervention: Minimally invasive transcatheter closure under the guidance of transesophageal ultrasound
Number of subjects: 100

Group type: COMPARATOR
Intervention: Minimally invasive transcatheter closure under the guidance of X-ray
Number of subjects: 100
Study: 32976660

Group type: EXPERIMENTAL
Intervention: 20 mg piroxicam
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 20 mg prednisolone
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 4 mg dexamethasone
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 33511868

Group type: EXPERIMENTAL
Intervention: Quickcast orthosis
Number of subjects: 58

Group type: COMPARATOR
Intervention: Orfilight thermoplastic custom‐fabricated orthosis
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Quickcast orthosis (soft tissue mallet group)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Orfilight thermoplastic custom‐fabricated orthosis (soft tissue mallet group)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 34671619

Group type: EXPERIMENTAL
Intervention: Balanced crystalloids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study: 32635408

Group type: EXPERIMENTAL
Intervention: Heat-killed Pediococcus acidilactici K15 (5 × 10^10 bacteria)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Dextrin (placebo)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Heat-killed Pediococcus acidilactici K15
Number of subjects: 172
Study: 35219633

Group type: EXPERIMENTAL
Intervention: Conflict Analysis (CA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Mindfulness (Control)
Number of subjects: 12
Study: 32993464

Group type: EXPERIMENTAL
Intervention: Angiographic Core Laboratory (ACL) analysis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cardiovascular Imaging Core Laboratory (CICL) analysis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Inter-core laboratory analysis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bland-Altman analysis for pre-MLD
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bland-Altman analysis for stent MLD
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bland-Altman analysis for acute gain
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bland-Altman analysis for late loss
Number of subjects: 50

Group type: COMPARATOR
Intervention: CICL analysis for pre-MLD
Number of subjects: 50

Group type: COMPARATOR
Intervention: CICL analysis for stent MLD
Number of subjects: 50

Group type: COMPARATOR
Intervention: CICL analysis for acute gain
Number of subjects: 50

Group type: COMPARATOR
Intervention: CICL analysis for late loss
Number of subjects: 50

Group type: COMPARATOR
Intervention: Coefficient of variation in lesion length, acute gain, late loss, and loss index
Number of subjects: 50
Study: 36228777

Group type: EXPERIMENTAL
Intervention: Medications-first arm
Number of subjects: 453

Group type: COMPARATOR
Intervention: Trabeculectomy-first arm
Number of subjects: 453
Study: 34174842

Group type: EXPERIMENTAL
Intervention: Carnosine (2 g/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33723973

Group type: EXPERIMENTAL
Intervention: Stachys sieboldii Miq granules
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33588822

Group type: EXPERIMENTAL
Intervention: Unsupervised, Supported
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Supervised, Supported
Number of subjects: 54

Group type: COMPARATOR
Intervention: Unsupervised, Unsupported
Number of subjects: 54
Study: 36184621

Group type: EXPERIMENTAL
Intervention: Hybrid trial design using external control datasets and randomization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Externally controlled trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized trial designs
Number of subjects: 0
Study: 32405735

Group type: EXPERIMENTAL
Intervention: PSMA-guided radiotherapy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: PSMA-guided radiotherapy with concomitant ADT or more than 24 fractions of radiation
Number of subjects: 86
Study: 32791950

Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering therapy (ILLT) comprising single LDL apheresis and statins
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard medical therapy (SMT) with no LDL apheresis and statin therapy alone
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering therapy (ILLT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard medical therapy (SMT)
Number of subjects: 160
Study: 36184349

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (group 1)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Radiofrequency ablation (group 2)
Number of subjects: 127
Study: 33581956

Group type: EXPERIMENTAL
Intervention: Posterior bending osteotomy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Grinding
Number of subjects: 38
Study: 34525901

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham dry needling
Number of subjects: 60
Study: 33592034

Group type: EXPERIMENTAL
Intervention: High Dimensional Selection with Interactions (HDSI) algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: LASSO, subset selection, adaptive LASSO, random LASSO, group LASSO
Number of subjects: 0
Study: 34986012

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT), 1500 mJ/cm2, three sessions/week for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Extracorporeal Shock Wave Therapy (ESWT), 0.05 mJ/mm2, one session/week for 4 weeks
Number of subjects: 40
Study: 32437192

Group type: EXPERIMENTAL
Intervention: Caffeine 1 mg/kg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Caffeine 3 mg/kg
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 32192292

Group type: EXPERIMENTAL
Intervention: Modified tubal resection or ligation
Number of subjects: 86

Group type: COMPARATOR
Intervention: Traditional tubal resection or ligation
Number of subjects: 86
Study: 34749275

Group type: EXPERIMENTAL
Intervention: Women's‐children's rights online course (14-week duration)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 32780096

Group type: EXPERIMENTAL
Intervention: Computer-aided indirect bonding
Number of subjects: 37

Group type: COMPARATOR
Intervention: Direct bonding
Number of subjects: 37
Study: 35485674

Group type: EXPERIMENTAL
Intervention: Omega 3 (flaxseed oil) 1gm three times daily for 3 months
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (lactose capsule) for 3 months
Number of subjects: 48
Study: 32495298

Group type: EXPERIMENTAL
Intervention: 10-year hip osteoporotic fracture probability
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: 10-year major osteoporotic fracture probability
Number of subjects: 264

Group type: COMPARATOR
Intervention: Guideline-recommended threshold for 10-year hip osteoporotic fracture
Number of subjects: 264

Group type: COMPARATOR
Intervention: Guideline-recommended threshold for 10-year major osteoporotic fracture
Number of subjects: 264
Study: 33350776

Group type: EXPERIMENTAL
Intervention: Nursing case management
Number of subjects: 200
Study: 35466954

Group type: EXPERIMENTAL
Intervention: Digital health technologies (DHTs) as secondary/exploratory outcome measures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional outcome measures
Number of subjects: 0
Study: 33998818

Group type: EXPERIMENTAL
Intervention: Exergame cognitive training with active tRNS stimulation
Number of subjects: 49

Group type: COMPARATOR
Intervention: Exergame cognitive training with sham tRNS stimulation
Number of subjects: 49

Group type: COMPARATOR
Intervention: No training with active tRNS stimulation
Number of subjects: 49

Group type: COMPARATOR
Intervention: No training with sham tRNS stimulation
Number of subjects: 49
Study: 32513111

Group type: COMPARATOR
Intervention: Caudal ropivacaine only (Control Group C)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Caudal ropivacaine plus 0.25 mg/kg ketamine (Group K0.25)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Caudal ropivacaine plus 0.5 mg/kg ketamine (Group K0.5)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Caudal ropivacaine plus 0.75 mg/kg ketamine (Group K0.75)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Caudal ropivacaine plus 1.0 mg/kg ketamine (Group K1.0)
Number of subjects: 169
Study: 34801607

Group type: EXPERIMENTAL
Intervention: Resistance Exercise Training (RET)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Quiet-rest (WL control)
Number of subjects: 62
Study: 616388369

Group type: EXPERIMENTAL
Intervention: Active psychological intervention based on routine nursing
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine nursing treatment
Number of subjects: 100
Study: 33584067

Group type: EXPERIMENTAL
Intervention: D-RIPC (donors received RIPC)
Number of subjects: 208

Group type: COMPARATOR
Intervention: S-RIPC (no intervention)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: R-RIPC (recipients received RIPC)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: DR-RIPC (both donors and recipients received RIPC)
Number of subjects: 208
Study: 32610573

Group type: EXPERIMENTAL
Intervention: CHO + CAF
Number of subjects: 10

Group type: COMPARATOR
Intervention: PLA
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CHO
Number of subjects: 10
Study: 35390535

Group type: EXPERIMENTAL
Intervention: Job-skills training in a contingency-management-based Therapeutic Workplace
Number of subjects: 161

Group type: COMPARATOR
Intervention: Workdays vs. non-workdays
Number of subjects: 161
Study: 34052569

Group type: EXPERIMENTAL
Intervention: Three 15-minute sessions of physiotherapy 5 days per week until discharge
Number of subjects: 76

Group type: COMPARATOR
Intervention: One 45-minute session of physiotherapy 5 days per week until discharge
Number of subjects: 76
Study: 35944773

Group type: EXPERIMENTAL
Intervention: Cardiac telerehabilitation (CTR) for 10 months
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard centre-based cardiac rehabilitation (CBCR)
Number of subjects: 56
Study: 33883664

Group type: EXPERIMENTAL
Intervention: FIFA Quality Pro artificial turf surface
Number of subjects: 15

Group type: COMPARATOR
Intervention: Non-certified pitch surface
Number of subjects: 15
Study: 36252131

Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 5669

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5669
Study: 33737321

Group type: EXPERIMENTAL
Intervention: eKidneyCare
Number of subjects: 182

Group type: COMPARATOR
Intervention: MyMedRec
Number of subjects: 182
Study: 33947627

Group type: EXPERIMENTAL
Intervention: Website engagement (intervention group)
Number of subjects: 17
Study: 32650887

Group type: EXPERIMENTAL
Intervention: Exercise to rhythmic music intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Active control group (brochure with exercise instructions)
Number of subjects: 20
Study: 33122168

Group type: EXPERIMENTAL
Intervention: Aprepitant (15-40 kg: 80 mg on days 1-3; >40 kg: 125 mg on day 1, 80 mg on days 2-3)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Ondansetron (0.15 mg/kg every 8 hours for 8 days)
Number of subjects: 78
Study: 34378860

Group type: EXPERIMENTAL
Intervention: Internal connection with microthreads (I-MT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Internal connection without microthreads (I-NMT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: External connection with microthreads (E-MT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: External connection without microthreads (E-NMT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Overall implants
Number of subjects: 25
Study: 35080588

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: 5.9% THC
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: 13.4% THC
Number of subjects: 191
Study: 33612484

Group type: EXPERIMENTAL
Intervention: Low-dose insulin infusion (0.05 Unit/kg/hour)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-dose insulin infusion (0.1 Unit/kg/hour)
Number of subjects: 60
Study: 33090908

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham remote ischemic conditioning (sham RIC)
Number of subjects: 24
Study: 35635326

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 763

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 763
Study: 33597521

Group type: EXPERIMENTAL
Intervention: TV003 vaccine
Number of subjects: 21
Study: 32781481

Group type: EXPERIMENTAL
Intervention: Dual-stained cytology (CINtec PLUS assay)
Number of subjects: 492

Group type: COMPARATOR
Intervention: HPV testing (cobas 4800 HPV Test)
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Dual-stained cytology combined with ASC-US threshold
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Dual-stained cytology combined with LSIL threshold
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Dual-stained cytology and HPV testing
Number of subjects: 492
Study: 34907823

Group type: EXPERIMENTAL
Intervention: Drynaria fortunei
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 34118470

Group type: EXPERIMENTAL
Intervention: CAD/CAM device (Narval CC™)
Number of subjects: 12

Group type: COMPARATOR
Intervention: non-CAD/CAM device (Narval™)
Number of subjects: 12
Study: 32030735

Group type: EXPERIMENTAL
Intervention: Regional anaesthesia (brachial plexus blocks)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Local anaesthesia/mixed
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Supraclavicular blocks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Future randomised controlled trial
Number of subjects: 39
Study: 35273351

Group type: COMPARATOR
Intervention: BNT162b2 mRNA COVID‐19 vaccine
Number of subjects: 32
Study: 33060543

Group type: EXPERIMENTAL
Intervention: Vascularized composite allografts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consensus data sets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collaborative efforts by field experts
Number of subjects: 0
Study: 34347623

Group type: EXPERIMENTAL
Intervention: Genetically determined age at menarche
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically determined age at menopause
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age at menarche
Number of subjects: 0
Study: 35405480

Group type: EXPERIMENTAL
Intervention: Moderate self-reported coffee consumption
Number of subjects: 114551

Group type: EXPERIMENTAL
Intervention: High genetically predicted coffee consumption
Number of subjects: 114551

Group type: EXPERIMENTAL
Intervention: High self-reported smoking
Number of subjects: 114551

Group type: EXPERIMENTAL
Intervention: High genetically predicted smoking
Number of subjects: 114551
Study: 33550995

Group type: EXPERIMENTAL
Intervention: Transdiagnostic psychological therapy (n = 527)
Number of subjects: 1061

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) (n = 534)
Number of subjects: 1061
Study: 35984511

Group type: EXPERIMENTAL
Intervention: Heated humidified high-flow nasal cannula (HFNC) oxygen therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional nasal catheter oxygen therapy
Number of subjects: 60
Study: 34217960

Group type: EXPERIMENTAL
Intervention: 20 mg of echinacea angustifolia, twice daily
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 40 mg of echinacea angustifolia, twice daily
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 36394873

Group type: EXPERIMENTAL
Intervention: PreVenture intervention
Number of subjects: 438

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 438
Study: 33168881

Group type: EXPERIMENTAL
Intervention: enrofloxacin (ENR)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: tulathromycin (TUL)
Number of subjects: 67

Group type: COMPARATOR
Intervention: no treatment (CTL)
Number of subjects: 67
Study: 36472990

Group type: EXPERIMENTAL
Intervention: Neural mobilization
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 88
Study: 33000332

Group type: EXPERIMENTAL
Intervention: HIIT (High-Intensity Interval Training)
Number of subjects: 22

Group type: COMPARATOR
Intervention: MICT (Moderate Intensity Continuous Training)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 22

Group type: COMPARATOR
Intervention: MICT
Number of subjects: 22
Study: 32681775

Group type: EXPERIMENTAL
Intervention: Psychological support for group a (on strict diet)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Psychological support for group b (on loos diet)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Psychological support for group c (off diet)
Number of subjects: 60
Study: 33675793

Group type: EXPERIMENTAL
Intervention: Vaginal estradiol
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Moisturizer
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dual placebo
Number of subjects: 120
Study: 32401086

Group type: EXPERIMENTAL
Intervention: IANB with additional buccal infiltration
Number of subjects: 120

Group type: COMPARATOR
Intervention: Buccal and lingual anaesthetic infiltration (INF)
Number of subjects: 120
Study: 35615800

Group type: EXPERIMENTAL
Intervention: ALND+ DEPART
Number of subjects: 265

Group type: COMPARATOR
Intervention: Standard ALND
Number of subjects: 265
Study: 33009991

Group type: EXPERIMENTAL
Intervention: ProSAAF program
Number of subjects: 346
Study: 35527116

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0